SCHEMBL1977993

SCHEMBL1977993

CCCOC(=O)C(=O)OCC

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
LMNA P02545 2/20 0.46
HSD17B10 Q99714 1/20 0.46
NPSR1 Q6W5P4 1/20 0.44
GLO1 Q04760 1/20 0.44
GAA P10253 2/20 0.43
ALOX15 P16050 1/20 0.43
MGAM O43451 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
SOAT1 P35610 1/20 0.43
TSHR P16473 3/20 0.43
HCAR2 Q8TDS4 1/20 0.43
THRB P10828 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 1/20 0.40
TRPA1 O75762 1/20 0.40
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL138475 0.91 HCAR2 (0.48) ALDH1A1LMNAHSD17B10NPSR1GAA
SCHEMBL28088707 0.91 HCAR2 (0.42) ALDH1A1LMNAHSD17B10NPSR1GLO1
Water SCHEMBL27557216 0.88 HCAR2 (0.46) ALDH1A1LMNAHSD17B10GAATSHR
SCHEMBL15536700 0.85 ALDH1A1 (0.47) ALDH1A1LMNAHSD17B10NPSR1GLO1
SCHEMBL7262 0.85 ALDH1A1 (0.62) ALDH1A1LMNAHSD17B10NPSR1GLO1
SCHEMBL9823358 0.85 ALDH1A1 (0.62) ALDH1A1LMNAHSD17B10NPSR1GLO1
SCHEMBL1331989 0.85 ALDH1A1 (0.62) ALDH1A1LMNAHSD17B10NPSR1GLO1
SCHEMBL7622799 0.84 ALDH1A1 (0.58) ALDH1A1LMNANPSR1TSHRHCAR2
SCHEMBL1982666 0.84 ALDH1A1 (0.58) ALDH1A1LMNANPSR1TSHRHCAR2
SCHEMBL1001162 0.84 THRB (0.64) ALDH1A1LMNAHSD17B10NPSR1GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698483-A1 COMPOSITIONS OF ORGANIC LIQUIDS, USES THEREOF FOR TRANSPORTING AND STORING HYDROGEN, AND HYDROGEN GENERATION METHODS USING SAME Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2026-02-25 EP claimed
WO-2024218386-A1 COMPOSITIONS OF ORGANIC LIQUIDS, USES THEREOF FOR TRANSPORTING AND STORING HYDROGEN, AND HYDROGEN GENERATION METHODS USING SAME COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2024-10-24 WO claimed
EP-0344519-B1 SUBSTITUTED 4-(QUINOLIN-2-YL-METHOXY)PHENYL-ACETIC-ACID DERIVATIVES BAYER AG (DE) 1993-04-14 EP claimed
EP-0239445-B1 1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXALDEHYDE OXIME DERIVATIVES, PROCESS FOR THEIR PREPARATION, COMPOSITIONS CONTAINING THEM AND THEIR USE AS MEDICINES ROUSSEL-UCLAF (FR) 1992-05-13 EP claimed
EP-0257296-A1 4-Cyano(nitro)-5-oxy(thio)-pyrazole derivatives BAYER AG (DE) 1988-03-02 EP claimed
EP-0236874-A2 Renin inhibitors, their production and use, as well as derivatives of amino acids and amino aldehydes BAYER AG (DE) 1987-09-16 EP claimed
US-20260103808-A1 ELECTROCHEMICAL REACTOR AND METHOD FOR PRODUCING OXYGEN-CONTAINING ORGANIC MATERIAL SEKISUI CHEMICAL CO., LTD. (JP) 2026-04-16 US disclosed
EP-4650489-A1 ELECTROCHEMICAL REACTOR AND METHOD FOR PRODUCING OXYGEN-CONTAINING ORGANIC MATERIAL Sekisui Chemical Co., Ltd. (JP) 2025-11-19 EP disclosed
US-12325923-B2 Electrochemical cell and method of producing carbonyl compound SEKISUI CHEMICAL CO., LTD. (JP) 2025-06-10 US disclosed
WO-2025028592-A1 ELECTROCHEMICAL REACTION DEVICE AND METHOD FOR PRODUCING ORGANIC SUBSTANCE 積水化学工業株式会社 2025-02-06 WO disclosed
US-12215435-B2 Electrochemical cell, method for producing carbonyl compound, and synthesis system SEKISUI CHEMICAL CO., LTD. (JP) 2025-02-04 US disclosed
US-20250011947-A1 ELECTROCHEMICAL CELL, METHOD FOR PRODUCING CARBONYL COMPOUND, AND SYNTHESIS SYSTEM SEKISUI CHEMICAL CO., LTD. (JP) 2025-01-09 US disclosed
EP-4477782-A1 ELECTROCHEMICAL CELL, AND CARBONYL COMPOUND PRODUCTION METHOD SEKISUI CHEMICAL CO., LTD. (JP) 2024-12-18 EP disclosed
EP-0301751-B1 PYRIDINIUM DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1993-03-10 EP disclosed
EP-0471236-A1 Imidazopyridine derivatives and their use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-02-19 EP disclosed
WO-1989002425-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-03-23 WO disclosed
EP-0301751-A1 Pyridinium derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1989-02-01 EP disclosed
US-4439229-A Substituted phthalimides herbicides ROHM AND HAAS COMPANY (US) 1984-03-27 US disclosed
US-4415494-A BLUE-TO-BLACK COLORFAST DISPERSE, NITRO DYES; DIAZOTIZING A P-NITROANILINE AND COUPLING WITH AN N-SUBSTITUTED 1-NAPHTHYLAMINE CASSELLA AKTIENGESELLSCHAFT (DE) 1983-11-15 US disclosed
EP-0068822-A2 Novel heterocyclic substituted benzenes, herbicidal compositions containing them and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1983-01-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103808-A1 ELECTROCHEMICAL REACTOR AND METHOD FOR PRODUCING OXYGEN-CONTAINING ORGANIC MATERIAL NOX1, NOXO1, HAO2 ALDH1A1 214/4885LMNA 4415/4885HSD17B10 1276/4885
US-20250011947-A1 ELECTROCHEMICAL CELL, METHOD FOR PRODUCING CARBONYL COMPOUND, AND SYNTHESIS SYSTEM CA2, CA12, OTC ALDH1A1 1724/4885LMNA 1090/4885HSD17B10 1414/4885
US-12215435-B2 Electrochemical cell, method for producing carbonyl compound, and synthesis system CA2, CA12, OTC ALDH1A1 1724/4885LMNA 1090/4885HSD17B10 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.